Trial · NCT01066039
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Month 6 | Bisoprolol | Baseline | 6.79 | Standard Deviation 0.66 | Percent HbA1c |
| Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Month 6 | Bisoprolol | Change at Month 6 | 0.26 | Standard Deviation 0.64 | Percent HbA1c |
| Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Month 3 | Bisoprolol | 0.15 | Standard Deviation 0.51 | Percent HbA1c | |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Mean Blood Pressure (BP) at Month 6 | Bisoprolol | SBP: Baseline | 147.8 | Standard Deviation 11.5 | mmHg |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Mean Blood Pressure (BP) at Month 6 | Bisoprolol | SBP: Change at Month 6 | -13.4 | Standard Deviation 15.4 | mmHg |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Mean Blood Pressure (BP) at Month 6 | Bisoprolol | DBP: Baseline | 89.0 | Standard Deviation 7.3 | mmHg |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Mean Blood Pressure (BP) at Month 6 | Bisoprolol | DBP: Change at Month 6 | -9.1 | Standard Deviation 9.0 | mmHg |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Mean Blood Pressure (BP) at Month 6 | Bisoprolol | Mean BP: Baseline | 108.6 | Standard Deviation 6.9 | mmHg |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Mean Blood Pressure (BP) at Month 6 | Bisoprolol | Mean BP: Change at Month 6 | -10.5 | Standard Deviation 10.2 | mmHg |
| Change From Baseline in Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) at Months 3 and 6 | Bisoprolol | Baseline | 2.3 | Standard Deviation 1.8 | mcIU/mL * mmol/L |
| Change From Baseline in Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) at Months 3 and 6 | Bisoprolol | Change at Month 3 | 0.1 | Standard Deviation 1.8 | mcIU/mL * mmol/L |
| Change From Baseline in Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) at Months 3 and 6 | Bisoprolol | Change at Month 6 | 0.4 | Standard Deviation 2.5 | mcIU/mL * mmol/L |
| Change From Baseline in Insulin Level at Months 3 and 6 | Bisoprolol | Baseline | 7.5 | Standard Deviation 4.8 | mcIU/mL |
| Change From Baseline in Insulin Level at Months 3 and 6 | Bisoprolol | Change at Month 3 | 0.2 | Standard Deviation 4.5 | mcIU/mL |
| Change From Baseline in Insulin Level at Months 3 and 6 | Bisoprolol | Change at Month 6 | 0.6 | Standard Deviation 6.0 | mcIU/mL |
| Change From Baseline in C-Peptide Level at Months 3 and 6 | Bisoprolol | Baseline | 2.3 | Standard Deviation 0.9 | nanogram per milliliter (ng/mL) |
| Change From Baseline in C-Peptide Level at Months 3 and 6 | Bisoprolol | Change at Month 3 | 0.1 | Standard Deviation 0.8 | nanogram per milliliter (ng/mL) |
| Change From Baseline in C-Peptide Level at Months 3 and 6 | Bisoprolol | Change at Month 6 | 0.2 | Standard Deviation 1.0 | nanogram per milliliter (ng/mL) |
| Change From Baseline in Total Cholesterol, Low Density Lipoprotein (LDL) Cholesterol, High Density Lipoprotein (HDL) Cholesterol and Triglyceride Level at Month 6 | Bisoprolol | Total Cholesterol: Baseline (n = 174) | 168.6 | Standard Deviation 32.3 | milligram per deciliter (mg/dL) |
| Change From Baseline in Total Cholesterol, Low Density Lipoprotein (LDL) Cholesterol, High Density Lipoprotein (HDL) Cholesterol and Triglyceride Level at Month 6 | Bisoprolol | Total Cholesterol: Change at Month 6 (n = 173) | -0.8 | Standard Deviation 26.3 | milligram per deciliter (mg/dL) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01066039/results